The NY Times shows poor scientific understanding in this hype 
for J Celera Venter  -  as I suggest by a few inserted comments.


January 24, 2008

Scientists Take New Step Toward Man-Made Life


Taking a significant step toward the creation of man-made forms of 
life, researchers reported Thursday that they had manufactured the 
entire genome of a bacterium by painstakingly stitching together its 
chemical components.

While scientists had previously synthesized the complete DNA of 
viruses, this is the first time it has been done for bacteria, which 
are much more complex.  The genome is more than 10 times as long as 
the longest piece of DNA ever previously synthesized.

The feat is a watershed for the emerging field called synthetic 
biology, which involves the design of organisms to perform particular 
tasks, such as making biofuels.  Synthetic biologists envision being 
able one day to design an organism on a computer, press the "print" 
button to have the necessary DNA made, and then put that DNA into a 
cell to produce a custom-made creature.

"What we are doing with the synthetic chromosome is going to be the 
design process of the future," said Dr. J. Craig Venter, the 
boundary-pushing gene scientist.  He assembled the team that made the 
bacterial genome as part of his well publicized quest to create the 
first synthetic organism.  The work was published online Thursday by 
the journal Science.

But there are concerns that synthetic biology could be used to make 
pathogens, or that errors by well-intended scientists could produce 
organisms that run amok.  The genome of the smallpox virus can in 
theory now be synthesized using the techniques reported on Thursday, 
since it is only about one-third the size of the genome manufactured 
by Dr. Venter's group.

In any case, there are many hurdles to overcome before Dr. Venter's 
vision of "life by design" is realized.  The synthetic genome made by 
Dr. Venter's team was not designed from scratch, but rather was a 
copy, with only a few changes, of the genetic sequence of a tiny 
natural bacterium called Mycoplasma genitalium.

Moreover, Dr. Venter's team, led by a Nobel laureate, Hamilton Smith, 
has so far failed to accomplish the next -and biggest - step.  That 
would be to insert the synthetic chromosome into a living microbe and 
have it "boot up" and take control of the organism's functioning.

If that happened, it would be considered by some to be the creation 
of the first synthetic organism.

	< There is no apparent reason why that should be deemed a 
synthetic organism any more than Dolly was.  Insert foreign DNA into 
a cell with (most of) its original DNA removed, and then if it lives 
on in some sense, using nearly all the natural parts of the cell  - 
synthetic my eye!

  The failure to achieve that so far has tempered the reception of 
some outside scientists.

"No matter how they praise the quality of the synthetic DNA, they 
have no idea whether it is biologically active," said Eckard Wimmer, 
a professor at Stony Brook University who created live polio virus in 
2002 using synthetic DNA and the publicly available genome sequence.

George M. Church, a professor of genetics at Harvard Medical School, 
said, "Right now, all they've done is shown they can buy a bunch of 
DNA and put it together."

Dr. Venter's team reported successfully doing such a chromosome 
transplant last year, but it involved the natural genome of one type 
of Mycoplasma being put into another species of that bacterium.

Dr. Venter said each pair of donor genome and recipient cell presents 
unique problems.  The scientists also think they interrupted the 
functioning of one crucial gene by their assembly process, a 
correctable problem.

"It's not a slam dunk, or we would be announcing it today," he told 
reporters.  Still, he expressed confidence, saying, "I will be 
equally surprised and disappointed if we can't do it in 2008."

The bacterial genome that was synthesized consisted of 582,970 base 
pairs, the chemical units of the genetic code that are represented by 
the letters A, C, G, and T.  The longest stretch of synthetic DNA 
previously reported in a scientific paper was about 32,000 bases 
long, though some gene synthesis companies say they can attach about 
50,000 bases.

The machines that can string together bases make lots of errors, so 
it is not practical to make a string of more than 50 to 100 bases at 
a time.  But some companies - the foundries of the biotechnology era 
- now make genes thousands of bases long by splicing those shorter 
strings together.

The Venter team ordered 101 such sequences, each 5,000 to 7,000 bases 
long, from these companies.  They then joined them together into 
bigger pieces and still bigger pieces.  In the final step, four big 
pieces were put into yeast, which hooked them together using a 
natural gene-repair mechanism.

The process was started in late 2002, Dr. Venter said, and 
undoubtedly cost millions of dollars.  That led some scientists to 
question why someone would want to synthesize an entire organism. 
Scientists can already make useful organisms - including some that 
are now starting to be make biofuels - by modifying existing ones 
using genetic engineering.

"It's not entirely clear to me what the immediate purpose of doing 
something like this is," said Jeremy Minshull, chief executive of DNA 
2.0, a company that supplied some of the DNA stretches to the Venter 
team.  "To some extent, it's something that was driven by 'I want to 
be the first person to do it.' "

Right now, Mr. Minshull said, scientists do not know enough about how 
living things work to design an entire genome: "Now our synthetic 
capability way outpaces our understanding of what we want to do."

For now, that is the case, Dr. Venter concedes.  He has a company, 
Synthetic Genomics, that is using genetic engineering to produce 

	< This is a deceptive wording.  Venter's propaganda
			does not claim that they are actually doing this. 

  It is using organisms other than Mycoplasma genitalium, which was 
chosen for the synthetic genome project because its genome is tiny, 
one-tenth the size of the genomes of some other bacteria.  But 
Mycoplasma is not suited to industrial production.

	<  quote:  At Synthetic Genomics Inc., we are developing 
novel genomic-driven strategies to address global energy and 
environmental challenges.  Recent advances in the field of synthetic 
genomics present seemingly limitless applications that could 
revolutionize production of energy, chemicals and pharmaceuticals and 
enable carbon sequestration and environmental remediation.  Given our 
team's longstanding history of pioneering science, we are uniquely 
positioned to ignite a biological industrial revolution, and we are 
committed to unlocking the keys to a clean energy

Still, Dr. Venter and some other scientists say that DNA synthesis is 
following the path of computer chips, with capability rising rapidly 
and cost - now about $1 per base - falling swiftly.  At some point, 
they say, it will become faster and cheaper for scientists to design 
and synthesize an organism from scratch rather than cut and paste 
genes from one organism to another, just as it is sometimes easier 
for a writer to type a fresh draft rather than edit an existing one.

The ability to synthesize genomes would allow for more scientific 
experimentation.  Dr. Venter said he would now be able to create 
organisms missing dozens of genes to answer the initial question that 
sparked the research ten years ago: What is the minimum set of genes 
needed for life?

Dr. Venter, who runs the nonprofit J. Craig Venter Institute in 
Rockville, Md., has been a pioneer in genomics.  He is best known for 
sequencing the human genome in a race with the publicly funded Human 
Genome Project.  The method his team used was novel at the time, but 
is now widely accepted.  It turned out that the genome his team 
sequenced was his own, making Dr. Venter the first person to have his 
complete DNA sequence published.

Some activist groups say Dr. Venter is going too far, too fast, this 
time, and that the entire field of synthetic biology needs outside 
regulation to prevent the introduction of dangerous organisms, 
created either by evil intent or by innocent error.

"The fact that he's pushing ahead with this without any societal 
oversight is very worrying," said Jim Thomas, a program manager at 
the ETC Group, an activist group based in Canada.  He also said it 
was worrisome that Dr. Venter was applying for very broad patents 
that could give him a near monopoly over the field of synthetic 

Dr. Venter said the synthetic biology field has been discussing 
ethics and safety steps since it started and that his work had been 
reviewed by ethicists.

In the new genome, he said, one gene was changed to make any 
resulting organism non-infective. (Mycoplasma genitalium, which can 
be transmitted sexually, is associated with inflammation, though its 
exact role in causing disease is not well understood.)

The team also added some DNA segments to the genome to serve as 
"watermarks," allowing scientists to distinguish the synthetic genome 
from the natural one.

That raises new possibilities of using microbes as a method of 
communication.   Dr. Venter said the watermarks contain coded 
messages.  Sleuths will have to determine the amino acid sequence 
coded for by the watermarks, in order to decipher the message.  "It's 
a fun thing that has a practical application," he said.

	< Could these inserted sequences be mainly to trace future 
patent infringements?